Drug-drug interaction with oral antivirals for the early treatment of COVID-19
Main Authors: | Alpo Vuorio, Frederick Raal, Petri T. Kovanen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971222006324 |
Similar Items
-
Drug-drug interaction with oral antivirals for early treatment of COVID-19 – Authors’ reply
by: Carsten Schade Larsen
Published: (2023-01-01) -
Familial Hypercholesterolemia Patients with COVID-19—Effective Cholesterol-Lowering Therapy is Urgent both during and after Infection
by: Alpo Vuorio, et al.
Published: (2022-12-01) -
Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir
by: Karolina Akinosoglou, et al.
Published: (2022-11-01) -
Assessing the proportion of the Danish population at risk of clinically significant drug-drug interactions with new oral antivirals for early treatment of COVID-19
by: Carsten Schade Larsen
Published: (2022-09-01) -
Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong Kong
by: Yue Yat Harrison Cheung, et al.
Published: (2024-01-01)